<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03187327</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0352</org_study_id>
    <nct_id>NCT03187327</nct_id>
  </id_info>
  <brief_title>Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology</brief_title>
  <acronym>FPS</acronym>
  <official_title>Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology and Evaluation of Occult Tubal Lesions Prevalence: Preliminary Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective study, patients who underwent vaginal hysterectomy with salpingectomy or
      salpingo-oophorectomy were included. The objective of this study is to assess the feasibility
      of prophylactic salpingectomy during vaginal hysterectomy for benign pathology and the
      prevalence of occult tubal lesions. The hypothesis is that prophylactic salpingectomy during
      vaginal hysterectomy for benign pathology present a low failure rate and it makes it possible
      to avoid the appearance of a certain number of ovarian cancers. The prevalence of bilateral
      salpingectomy with or without ovariectomy and the prevalence of histopathological and
      immunohistochemical (p53 expression) abnormalities were evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2013</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate of the surgical technique</measure>
    <time_frame>Day 0</time_frame>
    <description>prevalence of bilateral salpingectomy with or without ovariectomy</description>
  </primary_outcome>
  <enrollment type="Actual">69</enrollment>
  <condition>Salpingectomy</condition>
  <condition>Hysterectomy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent vaginal hysterectomy with salpingectomy or salpingo-oophorectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who underwent vaginal hysterectomy for benign pathology with salpingectomy or
             salpingo-oophorectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gautier CHENE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2017</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>June 13, 2017</last_update_submitted>
  <last_update_submitted_qc>June 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prophylactic salpingectomy</keyword>
  <keyword>vaginal hysterectomy</keyword>
  <keyword>p53 expression</keyword>
  <keyword>ovarian cancers</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

